Early Peanut Immunotherapy in Children (EPIC) trial: protocol for a pragmatic randomised controlled trial of peanut oral immunotherapy in children under 5 years of age

INTRODUCTION: Food allergy is a major public health challenge in Australia. Despite widespread uptake of infant feeding and allergy prevention guidelines the incidence of peanut allergy in infants has not fallen, and prevalence of peanut allergy in school-aged children continues to rise. Therefore,...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Sullivan, Michael David, Bear, Natasha, Metcalfe, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649730/
https://www.ncbi.nlm.nih.gov/pubmed/37963680
http://dx.doi.org/10.1136/bmjpo-2023-002294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649730/
https://www.ncbi.nlm.nih.gov/pubmed/37963680
http://dx.doi.org/10.1136/bmjpo-2023-002294

Ejemplares similares